Cardiovascular risk associated with low-dosed corticosteroid therapy in rheumatoid arthritis: Literature review;Risque cardiovasculaire associé à la corticothérapie à faible dose dans la polyarthrite rhumatoïde: revue de la littérature

Revue du Rhumatisme (Edition Francaise)

Volumn 77, Issue 6, 2010, Pages 542-549

  Ruyssen Witrand, Adeline ^a   Fautrel, Bruno ^b   Saraux, Alain ^c   Le Loët, Xavier ^d   Pham, Thao ^e  

^a Institut Cochin   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650355284     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2010.05.005     Document Type: Short Survey

References (50)

1. I.D. del Rincon, K. Williams, and M.P. Stern High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2001 2737 2745
2. D.H. Solomon, E.W. Karlson, and E.B. Rimm Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 2003 1303 1307
3. F. Wolfe, B. Freundlich, and W.L. Straus Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis J Rheumatol 30 2003 36 40
4. N. Sattar, D.W. McCarey, and H. Capell Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
5. S. Van Doornum, G. McColl, and I.P. Wicks Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46 2002 862 873
6. T. Pham, L. Gossec, and A. Constantin Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion Joint Bone Spine 73 2006 379 387
7. R.C. Andrews, and B.R. Walker Glucocorticoids and insulin resistance: old hormones, new targets Clin Sci (Lond) 96 1999 513 523
8. J.A. Whitworth, G.J. Mangos, and J.J. Kelly Cushing, cortisol, and cardiovascular disease Hypertension 36 2000 912 916
9. J.P. Girod, and D.J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res 64 2004 217 226
10. D.J. Nashel Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 80 1986 925 929
11. L. Wei, T.M. MacDonald, and B.R. Walker Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease Ann Intern Med 141 2004 764 770
12. S.T. Rab, S.B. King 3rd, and G.S. Roubin Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents J Am Coll Cardiol 18 1991 1524 1528
13. F. Versaci, A. Gaspardone, and F. Tomai Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study) J Am Coll Cardiol 40 2002 1935 1942
14. I. Hafstrom, M. Rohani, and S. Deneberg Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study J Rheumatol 34 2007 1810 1816
15. Y. Asanuma, S. Kawai, and H. Aoshima Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis Arthritis Rheum 42 1999 443 447
16. S.R. Dahlqvist, S. Engstrand, and E. Berglin Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy Scand J Rheumatol 35 2006 107 111
17. D. Heldenberg, D. Caspi, and O. Levtov Serum lipids and lipoprotein concentrations in women with rheumatoid arthritis Clin Rheumatol 2 1983 387 391
18. C. Garcia-Gomez, J.M. Nolla, and J. Valverde High HDL cholesterol in women with rhematoid arthritis on low-dose glucocorticoid therapy Eur J Clin Invest 38 2008 686 692
19. R. Westhovens, J. Nijs, and V. Taelman Body composition in rheumatoid arthritis Br J Rheumatol 36 1997 444 448
20. F. Wolfe, and K. Michaud The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis Arhtritis Rheum 58 2008 2612 2621
21. M. Mazzantini, M. Doveri, and A. Consensi Incidence of adverse effects during long-term, low-dose glucocorticoid treatment of rheumatoid arthritis Arthritis Rheum 56 2007 [Abstract 991]
22. A.A. van Everdingen, J.W. Jacobs, and D.R. Siewertsz Van Reesema Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial Ann Intern Med 136 2002 1 12
23. P.H. Dessein, B.I. Joffe, and A.E. Stanwix Glucocorticoids and insulin sensitivity in rheumatoid arthritis J Rheumatol 31 2004 867 874
24. G. La Montagna, F. Cacciapuoti, and R. Buono Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis Diab Vasc Dis Res 4 2007 130 135
25. D.A. Pappas, A. Rodriguez-Pla, and J.M. Bathon Glucocorticoid treatment is associated with increased insulin resistance in subjects with rheumatoid arthritis Arthritis Rheum 56 2007 [Abstract 992]
26. H.A. Capell, R. Madhok, and J.A. Hunter Lack of radiological and clinical benefit over 2 years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial Ann Rheum Dis 63 2004 797 803
27. P. Hickling, R.K. Jacoby, and J.R. Kirwan Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis arthritis and rheumatism council low dose glucocorticoid study group Br J Rheumatol 37 1998 930 936
28. V.F. Panoulas, K.M. Douglas, and A. Stavropoulos-Kalinoglou Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis Rheumatology (Oxford) 47 2008 72 75
29. C.P. Chung, A. Oeser, and J.F. Solus Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis Atherosclerosis 196 2008 756 763
30. R. Roubenoff, P. Dellaripa, and M.R. Nadeau Abnormal homocysteine metabolism in rheumatoid arthritis Arthritis Rheum 1997 718 722
31. H. Sato, J.J. Kazama, and Y. Wada Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis Intern Med 46 2007 1685 1691
32. I. del Rincon, D.H. O'Leary, and R.W. Haas Effect of glucocorticoids on the arteries in rheumatoid arthritis Arthritis Rheum 50 2004 3813 3822
33. P.H. Dessein, B.I. Joffe, and M.G. Veller Traditional and non traditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis J Rheumatol 32 2005 435 442
34. P.H. Dessein, G.R. Norton, and A.J. Woodiwiss Influence of non classical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis J Rheumatol 34 2007 943 951
35. C. Gonzalez-Juanatey, J. Llorca, and A. Testa Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease Medicine (Baltimore) 82 2003 407 413
36. Y. Kumeda, M. Inaba, and H. Goto Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum 46 2002 1489 1497
37. A. Pahor, R. Hojs, and M. Gorenjak Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis Rheumatol Int 27 2006 119 123
38. Y.B. Park, C.W. Ahn, and H.K. Choi Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound Arthritis Rheum 46 2002 1714 1719
39. K.M. Maki-Petaja, F.C. Hall, and A.D. Booth Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by antitumor necrosis factor-alpha therapy Circulation 114 2006 1185 1192
40. K. Tanaka, M. Inaba, and H. Goto Para-articular trabecular bone loss at the ultradistal radius and increased arterial stiffening in postmenopausal patients with rheumatoid arthritis J Rheumatol 33 2006 652 658
41. E. Arosio, S. De Marchi, and A. Rigoni Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis J Hypertens 25 2007 1273 1278
42. C. Gonzalez-Juanatey, A. Testa, and A. Garcia-Castelo Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease Semin Arthritis Rheum 33 2004 231 238
43. C. Montecucco, G. Gobbi, and S. Perlini Impaired diastolic function in active rheumatoid arthritis relationship with disease duration Clin Exp Rheumatol 17 1999 407 412
44. D.A. Anichkov, N.A. Shostak, and D.S. Ivanov Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients Int J Clin Pract 61 2007 777 783
45. Z. Nadareishvili, K. Michaud, and J.M. Hallenbeck Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study Arthritis Rheum 59 2008 1090 1096
46. J.M. Davis 3rd, H. Maradit Kremers, and C.S. Crowson Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 56 2007 820 830
47. D.H. Solomon, J. Avorn, and J.N. Katz Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis Arthritis Rheum 54 2006 3790 3798
48. M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, and M.J. Lopez-Diaz HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis Arthritis Rheum 57 2007 125 132
49. A. Ruyssen-Witrand, G. Mouterde, and E. Dernis Tolérance des glucocorticoïdes dans la polyarthrite rhumatoïde: élaboration de recommandations pour la pratique clinique partir d'une analyse systématique de la littérature et de l'opinion d'experts. Édition spéciale rencontres d'experts en rhumatologie Rev Rhum 75 2008 S22 S28
50. I. del Rincon, S. Pogosian, and A. Escalante Daily and cumulative threshold glucocorticoid dose associated with cardiovascular and all-cause mortality in rheumatoid arthritis Arthritis Rheum 56 2007 [Abstract 289]